Is Turning Point Brands (TPB) Cheap As Conference Buzz And UK Exposure Grow?
Conference spotlight and new European partnership draw attention to Turning Point Brands
Turning Point Brands (TPB) is back on investor radars after presenting at the 17th Annual Midwest IDEAS Conference in Chicago and highlighting fresh brand exposure from its ALP nicotine pouch partnership with Matchroom Boxing in the UK and Ireland.
Despite the fresh attention from conference exposure and the Matchroom Boxing partnership, Turning Point Brands’ recent share price performance has been weak. The stock is down 30.21% on a year-to-date share price basis, while still showing a very large 3-year total shareholder return of 235.09%. This suggests that long-term holders have experienced a very different journey compared with more recent buyers.
Compare Turning Point Brands’ recent pullback and long-term strength with a curated set of resilient market ideas through our 79 resilient stocks with low risk scores.
After a 30% pullback this year, but a very large 3 year total return, Turning Point Brands presents a very different picture depending on your entry point. Do the current fundamentals and price still leave enough upside for the risk?
Most Popular Narrative: 40.8% Undervalued
Compared with the last close at $76.94, the most followed narrative for Turning Point Brands points to a fair value of $130 and a sizeable valuation gap.
The company's ability to grow its premium brands in high-margin niches (e.g., Stoker's MST and Zig-Zag) while maintaining strong customer loyalty and executing pricing actions, even as legacy segments decline, underpins stable or improving net margins and cash generation through industry transitions.
Want to see why this narrative backs such a big valuation gap? The story leans on fast compounding earnings, strong revenue expansion, and richer margins baked into the model.
The narrative framework uses a discount rate of 7.94% and ties that to ambitious assumptions for where Turning Point Brands’ revenue, earnings and profitability might land over the next few years. It also builds in a richer future earnings multiple than the broader tobacco industry, which helps bridge the gap between today’s price and the $130 fair value figure.
Result: Fair Value of $130 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Turning Point Brands still faces meaningful risks if Modern Oral growth underwhelms, or if tougher regulation on nicotine pouches and flavours affects future revenue and margins.
Find out about the key risks to this Turning Point Brands narrative.
Another view on Turning Point Brands’ valuation
The most followed narrative points to Turning Point Brands being 40.8% undervalued, yet the current P/E of 34.6x is higher than the 32.7x fair ratio and far above the Global Tobacco average of 11.2x. That raises a simple question: How much optimism is already in the price?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of upside and risk around Turning Point Brands feels finely balanced, consider acting promptly and reviewing the full range of signals through 2 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Turning Point Brands?
If Turning Point Brands has sharpened your focus on risk and reward, do not stop here. Use the Simply Wall Street Screener to spot other opportunities that fit your style.
- Spot potential mispricing across the market and review a 52 high quality undervalued stocks that combines quality fundamentals with attractive valuations.
- Strengthen the income side of your portfolio by checking out a 11 dividend fortresses that focuses on companies with higher yields and robust payout profiles.
- Prioritise resilience and financial discipline by scanning a list of solid balance sheet and fundamentals (53 results) that highlights companies with stronger balance sheets and solid fundamentals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com